Literature DB >> 13893560

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

A P FLETCHER, N ALKJAERSIG, S SHERRY.   

Abstract

Entities:  

Keywords:  FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HEMORRHAGIC DIATHESIS/etiology

Mesh：

Substances：

Year:  1962        PMID： 13893560      PMCID： PMC290991          DOI： 10.1172/JCI104546

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  55 in total

1.  Pathogenesis of hypofibrinogenemia in placental abruption.

Authors:  J A PRITCHARD; M R WRIGHT
Journal:  N Engl J Med       Date:  1959-07-30       Impact factor: 91.245

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Defibrination syndrome in pregnancy: value of various diagnostic tests.

Authors:  A A SHARP; B HOWIE; R BIGGS; D T METHUEN
Journal:  Lancet       Date:  1958-12-20       Impact factor: 79.321

4.  Studies on the thrombolytic activity of human plasma.

Authors:  W D SAWYER; A P FLETCHER; N ALKJAERSIN; S SHERRY
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

5.  Coagulation components in normal and abnormal pregnancies.

Authors:  O D RATNOFF; T R HOLLAND
Journal:  Ann N Y Acad Sci       Date:  1959-01-09       Impact factor: 5.691

6.  Biosynthetic determination with radioactive sulfur of turn-over rates of various plasma proteins in normal and cirrhotic man.

Authors:  W VOLWILER; P D GOLDSWORTHY; M P MACMARTIN; P A WOOD; I R MACKAY; K FREMONT-SMITH
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

7.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

8.  Abnormal plasma proteolytic activity; diagnosis and treatment.

Authors:  E V SCOTT; W F MATTHEWS; C E BUTTERWORTH; W B FROMMEYER
Journal:  Surg Gynecol Obstet       Date:  1954-12

9.  The purification of human fibrinogen.

Authors:  R A KEKWICK; M E MACKAY; M H NANCE; B R RECORD
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

10.  Prothrombin and Fibrinolysin.

Authors:  W H Seegers; E C Loomis
Journal:  Science       Date:  1946-11-15       Impact factor: 47.728
View more
  23 in total

1.  HAEMORRHAGE AND FIBRINOLYSIS.

Authors:  P T FLUTE
Journal:  Proc R Soc Med       Date:  1964-07

2.  CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.

Authors:  N ENDE; J V AUDITORE
Journal:  Ann Surg       Date:  1963-07       Impact factor: 12.969

Review 3.  CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.

Authors:  J LIEBERMAN
Journal:  Calif Med       Date:  1963-11

4.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors:  A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

5.  TO-DAY'S DRUGS. FIBRINOLYTIC ENZYMES AND FIBRINOLYTIC INHIBITORS.

Authors:  J H HUTCHISON
Journal:  Br Med J       Date:  1965-03-13

6.  [Thromboelastographic studies on the blood clot structure in the Sanarelli-Shwartzman phenomenon].

Authors:  G MULLER-BERGHAUS; H J KRECKE; H G LASCH
Journal:  Klin Wochenschr       Date:  1963-03-01

7.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

8.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

Authors:  N U BANG; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

9.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

10.  Thrombolytic Therapy.

Authors: 
Journal:  Br Med J       Date:  1963-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.